- Home
- DCGO vs AQST Comparison
DCGO vs AQST Comparison
Compare DCGO & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCGO
- AQST
- Stock Information
- Founded
- DCGO 2015
- AQST 2004
- Country
- DCGO United States
- AQST United States
- Employees
- DCGO N/A
- AQST N/A
- Industry
- DCGO Managed Health Care
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- DCGO Health Care
- AQST Health Care
- Exchange
- DCGO Nasdaq
- AQST Nasdaq
- Market Cap
- DCGO 272.3M
- AQST 274.4M
- IPO Year
- DCGO N/A
- AQST 2018
- Fundamental
- Price
- DCGO $2.64
- AQST $3.02
- Analyst Decision
- DCGO Strong Buy
- AQST Strong Buy
- Analyst Count
- DCGO 5
- AQST 7
- Target Price
- DCGO $5.30
- AQST $10.57
- AVG Volume (30 Days)
- DCGO 985.6K
- AQST 1.3M
- Earning Date
- DCGO 05-07-2025
- AQST 03-05-2025
- Dividend Yield
- DCGO N/A
- AQST N/A
- EPS Growth
- DCGO 200.00
- AQST N/A
- EPS
- DCGO 0.18
- AQST N/A
- Revenue
- DCGO $616,555,132.00
- AQST $57,561,000.00
- Revenue This Year
- DCGO N/A
- AQST N/A
- Revenue Next Year
- DCGO $7.65
- AQST $35.72
- P/E Ratio
- DCGO $14.75
- AQST N/A
- Revenue Growth
- DCGO N/A
- AQST 13.79
- 52 Week Low
- DCGO $2.63
- AQST $2.24
- 52 Week High
- DCGO $5.68
- AQST $5.80
- Technical
- Relative Strength Index (RSI)
- DCGO 28.36
- AQST 50.92
- Support Level
- DCGO $2.63
- AQST $3.05
- Resistance Level
- DCGO $2.86
- AQST $3.24
- Average True Range (ATR)
- DCGO 0.14
- AQST 0.20
- MACD
- DCGO 0.05
- AQST 0.04
- Stochastic Oscillator
- DCGO 2.22
- AQST 57.47
About DCGO DocGo Inc.
DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. The company uses its care delivery platform to provide mobile health services, virtual care management, and ambulance services. It has three reporting segments: Mobile Health Services, Transportation Services, and Corporate. A majority of its revenue is generated from the Mobile Health Services segment, which includes various healthcare services performed at homes, offices, and other locations and event services such as on-site healthcare support at sporting events and concerts. Geographically, the company generates a majority of its revenue from the United States and the rest from the United Kingdom.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.